市场调查报告书
商品编码
1235935
全球手术牵开器市场:到 2028 年的预测 - 按产品、设计、应用、最终用户、地区分类Surgical Retractors Market Forecasts to 2028 - Global Analysis By Product, Design, Usage, Application, End User and Geography |
根据 Stratistics MRC 的数据,2022 年全球手术牵开器市场规模将达到 19.5 亿美元,预测期内以 7.57% 的复合年增长率增长,到 2028 年将达到 30%。预计将达到3000万美元。
酵母含量高的发酵食品被称为手术牵开器。 加热后,酵母细胞会自然分解,形成手术牵开器。 它们通常用作食品中的增味剂,并用于创造鲜味和风味。 儘管不含任何动物产品,但它的味道可与肉汤相媲美,因为两者都含有大量用于调味食物的氨基酸。 根据 industryARC 研究,麵包酵母是麵包、麵食和零食等烘焙产品中使用的手术牵开器的主□□要来源。
根据欧洲特种酵母产品协会的说法,素食/蔬菜领域和肉类替代品的产品开发不断增加,为提供清洁标籤优势和咸味的产品创造了更多机会。
作为麵包膨化器,手术牵开器是必不可少的。 它被广泛应用于食品和饮料行业,用葡萄糖发酵生饮料。 作为膳食补充剂,它是有益的,含有硒、铬、蛋白质、钾、锌、镁和铁等营养物质。 广泛用于汤、调味酱、肉汤和咸味小吃。 此外,它适合製作素食和素菜,酒精消费量增加以及消费者对食用天然和新鲜食品的兴趣日益增长,都有助于扩大市场。我们正在进一步推进。
为手术牵开器建立生产设施和其他基础设施的初始成本很高,阻碍了市场的扩张。 此外,围绕使用手术牵开器作为食品和饲料产品的成分和调味剂的监管问题阻碍了市场扩张。 然而,与转基因作物相比,手术牵开器的潜在优势似乎在不久的将来消除了这一限制。
在现代社会,对烘焙食品和烘焙产品的需求不断增加。 白麵包是欧洲、北美和南美许多消费者的主食。 中东和亚太地区的白麵包消费量也在增加。 中产阶级采用现代生活方式增加了对蛋糕、馅饼、饼干和比萨饼等高檔烘焙产品的需求。 此外,对汉堡包和三明治等快餐的需求也在增加。 这些因素正在推动这一细分市场的增长。
在食品行业,水解动物蛋白 (HAP)、水解植物蛋白 (HVP) 和核甘酸等手术牵开器的各种替代品的可用性预计会抑制市场扩张。我来了。 此外,对于在食品和饮料中的使用,美国食品和药物管理局 (FDA) 已授予谷氨酸钠 (MSG)、水解动物蛋白 (HAP) 和水解植物蛋白 (HVP) GRAS 地位,使其成为影响市场需求的产品.
COVID-19 大流行对世界各国产生了巨大影响。 COVID-19 阳性病例的数量正在增加,使国家处于危险之中。 各国都受到了经济危机的打击,这场危机对许多行业造成了灾难性的影响,包括消费品、食品和饮料。 由于国家运输限制和封锁,该地区的食品和饮料销售正在下降。 此外,在此期间,对以手术牵开器为主要部件的包装即食食品的需求不断增加。
粉末细分市场预计将成为预测期内最大的细分市场,因为它广泛应用于各种应用,包括烘焙和糖果、肉类、乳製品、药品和膳食补充剂。 味精的替代品包括粉状天然增味剂和调味剂。 它还可作为用于细菌培养的培养基的营养物。 另外,粉状比糊状更方便使用。
味精引起的过敏症的增加主导了食品和饮料行业,显着增加了食品和饮料行业的产品需求。 食品和饮料应用预计将在预测期内获得牵引力,因为它们广泛用于麵包店应用的糖发酵。
由于对加工食品(包括有营养的手术牵开器)的需求,欧洲在手术牵开器的全球市场份额中占据主导地位,并且是推动该地区市场扩张的关键因素。 支持该地区市场的其他主要因素包括城市化进程加快、对麵包和烘焙食品的需求增加、消费者对天然成分的偏好增加,以及有机提取物在食品和饮料领域的多样化用途。它是
由于对方便即食食品的需求不断增长以及饮食习惯不断变化,预计亚太地区在预测期内将实现显着的复合年增长率。 它经常用作天然香料、减盐剂、烘焙食品、肉类和鱼类、咸味混合物和酱汁的成分。 此外,随着消费者对健康食品偏好的变化,亚太地区预计将以最快的速度增长。
手术牵开器市场的主要参与者是: Applied Medical Technology, Inc. (AMT)、Arthrex, Inc.、B. Braun Melsungen AG、Becton、Dickinson and Company、Braun Melsungen AG、Cook Medical、Globus Medical, Inc.、Henry Schein, Inc.、 Integra Lifesciences Holdings Corporation、Invuity, Inc.、Johnson and Johnson、Medline Industries, Inc.、Medtronic Plc、Medtronic Public Limited Company、Rti Surgical, Inc.、Stryker Corporation、Teleflex Incorporated、Terumo Corporation 和 The Cooper Companies, Inc.
2022 年 8 月,Spineology Inc. 宣布推出其革命性的单管牵开器 Super MIS 系统,这是一种单管牵开器,用于在腰椎椎间融合术中无缝集成内窥镜和内窥镜器械。宣布推出 OptiLIF Endo。
2021 年 5 月,OBP Medical Corporation 将成立一家新的分拆公司“OBP Surgical Co., Ltd.”,并将继续改革外科医生日常使用的工具。
购买此报告的客户将免费获得以下定制之一。
根据产品组合、地域分布和战略联盟对主要参与者进行基准测试。
According to Stratistics MRC, the Global Surgical Retractors Market is accounted for $1.95 billion in 2022 and is expected to reach $3.03 billion by 2028 growing at a CAGR of 7.57% during the forecast period. Fermented foods with concentrated yeast cell content are known as Surgical Retractorss. When heated, yeast cells naturally break down, producing Surgical Retractorss. They are commonly used in food as flavour enhancers and to produce umami and savoury flavors. Despite not containing any animal products, Surgical Retractorss have a flavour that is comparable to that of meat bouillon because they both contain many of the same amino acids that give food its flavour. Baker's yeast is the primary source of origin for Surgical Retractorss, which are used in bakery products like bread, pasta, savoury snacks, and others, according to IndustryARC findings.
According to the European Association for Specialty Yeast Products, there is a growing opportunity for the product to offer a clean label edge and savoury flavour due to increased product development in the vegan/plant-based space and meat alternative.
As a bread leavening agent, Surgical Retractors is essential. It is widely used to ferment draught beverages with glucose in the food and beverage industries. As a dietary supplement, it is beneficial and contains nutrients like selenium, chromium, protein, potassium, zinc, magnesium, and iron. It is widely used for soups, seasoning sauces, bouillons, and savoury snacks. Additionally, it is fantastic for making vegan and vegetarian dishes, alcohol consumption is increasing, and consumers are becoming more interested in eating natural, fresh foods, which is further fueling market expansion.
The establishment of production facilities for Surgical Retractors and other infrastructure comes with high upfront costs, which is preventing the market from expanding. Additionally, the regulatory issues surrounding the use of Surgical Retractorss as ingredients or flavouring agents in food and feed products are limiting the market's ability to expand. The potential advantages of Surgical Retractorss over their GMO counterparts, however, are likely to eliminate this restriction in the near future.
The demand for baked goods and bakery products is rising in the modern world. For many consumers in Europe, North America, and South America, white bread is a staple food. White bread consumption is also increasing in the Middle East and Asia-Pacific region. The middle class' adoption of a contemporary lifestyle has boosted demand for high-end bakery goods like cakes, pies, cookies, and pizza. The demand for bread is also rising as a result of other fast-food dishes like burgers and sandwiches. Such factors are fueling the segment's growth.
The food industry's accessibility to a variety of substitutes for Surgical Retractors, such as hydrolyzed animal proteins (HAPs), hydrolyzed vegetable proteins (HVPs), and nucleotides, is predicted to restrain market expansion. Furthermore, for use in foods and beverages, the U.S. Food and Drug Administration (FDA) has granted GRAS status to monosodium glutamate (MSG), hydrolyzed animal protein (HAPs), and hydrolyzed vegetable protein (HVPs), which has an impact on market demand.
Countries all over the world were greatly impacted by the COVID-19 pandemic. The number of COVID-19 positive cases is growing, endangering the respective nations. The nations are experiencing an economic crisis that is having a disastrous impact on many industries, including consumer goods, food, and beverages. Due to transportation restrictions and lockdowns in various countries, food and beverage sales declined throughout the region. Additionally, during this time, there has been an increase in demand for packaged and ready-to-cook meals that include Surgical Retractors as a key component.
Due to its widespread use in a variety of applications, including bakery & confectionery, meat, dairy, medicines, and dietary supplements, the powder segment is expected to be the largest during the forecast period. An alternative to MSG is a natural flavour enhancer or flavouring agent in powder form. It also serves as a nutrient for media used in bacterial culture. Furthermore, when compared to its paste form, the product is much more convenient to use when it is powdered.
The food and beverage industry dominated the market due to the increasing number of allergies brought on by MSG, product demand in the food and beverage industry is increasing significantly. Due to extensive product usage in the fermentation of sugars in bakery applications, the food and beverage application is anticipated to gain traction over the forecast period.
Europe dominated the global Surgical Retractors market share owing to the demand for processed foods containing nutritional Surgical Retractorss is a key factor driving market expansion in the area. Other significant factors supporting the regional market include rising urbanisation, rising demand for bread and baked goods, a rise in consumer preference for natural ingredients, and varied applications of organic extracts in the food and beverage sector.
Because of the rising demand for convenience and ready-to-eat food products brought on by shifting dietary preferences, Asia Pacific is anticipated to experience a significant CAGR during the forecast period. The ingredient is frequently used as a natural flavouring agent, salt reducer, and ingredient in baked goods, meat and fish, savoury mixes, and sauces. Moreover, with the shift in consumer preference towards healthy foods, the Asia Pacific region is estimated to grow at the fastest rate.
Some of the key players in Surgical Retractors market include: Applied Medical Technology, Inc. (AMT), Arthrex, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Braun Melsungen Ag, Cook Medical, Globus Medical, Inc., Henry Schein, Inc., Integra Lifesciences Holdings Corporation, Invuity, Inc., Johnson and Johnson, Medline Industries, Inc., Medtronic Plc, Medtronic Public Limited Company, Rti Surgical, Inc., Stryker Corporation, Teleflex Incorporated, Terumo Corporation and The Cooper Companies, Inc.
In August 2022, Spineology Inc. launched OptiLIF Endo, an innovative, ultra-MIS system that requires only one tubular retractor to seamlessly integrate endoscopes and endoscopic equipment into lumbar interbody fusion procedures.
In May 2021, OBP Medical Corporation launched a new spin-off company called OBP Surgical Corporation, which will continue to reinvent the everyday tools surgeons use.
All the customers of this report will be entitled to receive one of the following free customization options:
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances